.AstraZeneca executives claim they are "certainly not concerned" that the failing of tozorakimab in ...
.Accept to today's Chutes & Ladders, our summary of considerable leadership hirings, firings and ...
.After revealing strategies to attack the U.S. public markets lower than a month back, Zenas Biophar...
.Psyence Biomedical is actually paying out $500,000 in shares to obtain fellow psilocybin-based biot...
.5 months after endorsing Utility Therapeutics' Pivya as the 1st new treatment for easy urinary syst...
.Eli Lilly has sprung into an AI-enabled medication invention package, partnering with RNA specialis...
.Lykos chief executive officer and also owner Amy Emerson is actually walking out, with principal op...
.Novartis is opening a brand new frontier in its partnership with Voyager Therapies, paying out $15 ...
.On the heels of an FDA being rejected for its own primary competing Novo Nordisk, Eli Lilly is push...
.Merely a couple of months after dosing the first patient in a period 2 test for newly diagnosed gli...